SHENZHEN, SHENZHEN, CHINA, January 20, 2026 /EINPresswire.com/ -- The global shift towards hybrid and remote work ...
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
A regulatory setback for Moderna’s next-generation flu vaccine underscores mounting scrutiny of late-stage trial design in the U.S., even as the company pivots to international manufacturing ...
Moderna Inc. MRNA stock fell Wednesday as the company faced a setback following a refusal-to-file letter from the U.S. Food ...
Rezoning decision opens sacred Dan River lands to heavy industry despite community opposition and unresolved cultural ...